VBI Vaccines

145 articles with VBI Vaccines

• VBI Vaccines Announces Proposed Concurrent Public Offering and Registered Direct Offering of Common Shares

  10/26/2017

  VBI also intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the number of common shares offered in the public offering.

• VBI Vaccines Booming in Kendall Square, Ottawa and Israel

  10/9/2017

• VBI Vaccines Reports Positive Outcome From Phase III Pre-IND Discussions With The FDA For Hepatitis B Vaccine, Sci-B-Vac

  6/19/2017

• Meet VBI Vaccines, The Biotech Up 100% In 2017

  3/8/2017

• VBI Vaccines Receives Positive Response From Health Canada’s Initial Evaluation Of The Proposed Sci-B-Vac Phase III Clinical Program

  2/22/2017

• VBI Vaccines Receives Positive EMA Scientific Advice Regarding Sci-B-Vac Phase III Clinical Study

  2/7/2017

• VBI Vaccines Completes Pre-IND Meeting For Its Glioblastoma Immunotherapy Candidate

  10/12/2016

• VBI Vaccines Completes Enrollment Of Participants In The Phase I Clinical Trial Of Its Preventative Cytomegalovirus Vaccine Candidate

  9/20/2016

• VBI Vaccines To Present At The World Vaccine Congress Washington

  3/29/2016

• VBI Vaccines Presents New Data Supporting Its Glioblastoma Immunotherapy Program At The Keystone Symposia Cancer Vaccines Conference

  3/7/2016

• VBI Vaccines To Present At The LD Micro Conference

  11/25/2015

• VBI Vaccines Presents Update And New Data Supporting Its Glioblastoma Immunotherapy Program At The ESMO Symposium On Immuno-Oncology

  11/20/2015

• VBI Vaccines To Present Update And New Data Supporting Its RSV And CMV Vaccine Programs At The World Vaccine Congress Europe

  11/6/2015

• VBI Vaccines And SciVac Therapeutics To Live Webcast Joint Conference Call For Shareholders To Discuss Proposed Merger

  11/4/2015

• VBI Vaccines And Scivac Therapeutics To Hold Joint Conference Call For Shareholders To Discuss Proposed Merger

  10/30/2015

• VBI Vaccines Announces Development Of A Novel Glioblastoma Immunotherapy Candidate

  10/8/2015

• VBI Vaccines To Present At The 15th Annual Biotech In Europe Forum

  9/24/2015

• VBI Vaccines Promotes Dr. David E. Anderson To Chief Scientific Officer

  9/14/2015

• VBI Vaccines Awarded NRC-IRAP Funding To Leverage Its Evlp Platform In The Development Of A Novel RSV Vaccine Candidate

  9/9/2015

• VBI Vaccines To Present At The Rodman & Renshaw 17th Annual Global Investment Conference

  9/3/2015